Navigation Links
New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting

ar to the rationale for the aforementioned, Memorial Sloan-Kettering study, this Phase 1 trial was designed to evaluate toxicity and preliminary efficacy of the combination of docetaxel plus QUADRAMET administered sequentially in advanced HRPC.

Preliminary data was published for 10 patients who received repeated doses of the combination of QUADRAMET (at the full FDA-approved doses of 1.0 mCi/kg every 12 weeks for a maximum of two cycles) and escalating doses of docetaxel (at doses up to 75 mg/m(2) every three weeks). All patients had bone metastases and all symptomatic patients (seven of seven) had improvement of pain. Median baseline PSA was 77 ng/ml and four of 10 patients achieved a 50% decline that lasted for four or more weeks.

The authors concluded that the data suggest that the combination of QUADRAMET and docetaxel may be administered simultaneously at the full approved doses in extensively pretreated HRPC patients with acceptable toxicity and significant activity.

"A Phase 2 trial of docetaxel and samarium in patients with bone metastases from castration-refractory prostate cancer (CRPC)" by Laplanche, A. et al. (Abstract No. 5122, Poster No. G4)

In a prospective, Phase 2 investigator-sponsored trial investigators reported on long-term pain responses, disease progression and survival in patients treated with a combination of QUADRAMET and docetaxel/estramustine. Forty-three patients with CRPC were administered docetaxel (70 mg/m(2) per cycle) on three week intervals for three cycles which was followed by a weekly dosing schedule of docetaxel (20 mg/m(2) per cycle for six cycles) during which a single dose of QUADRAMET (1.0 mCi/kg) was administered in combination with the first dose of docetaxel. The authors reported a median prostate specific antigen (PSA) progression-free survival rate of seven months, a median survival of approximately 30 months, and concluded the combination was feasible, well tolerated, and associated with a
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Preclinical Data on Cytogens Technology to be Reported at the AACR Annual Meeting
2. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
3. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
4. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
5. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
7. VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
8. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
9. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
10. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Data for Cytogen QUADRAMET Reported Annual ASCO Meeting
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... (NYSE: RMD ) today announced results for its ... $423.0 million, a 10 percent increase compared to the quarter ... constant currency basis). Net income was $91.2 million, an increase ... 2013. Diluted earnings per share for the quarter were $0.64, ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the basic ... , Purchasing an accidental death and dismemberment rider for a ... rider provides benefits if the insured dies in an accident. ... of life insurance. , AD&D is not expensive and ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Clinic in West Palm BeachMERRIMACK, N.H., Jan. 28 ... body shaping, announced a new partnership with Anushka and ... in West Palm Beach. The 12,000 square foot ... the Palm Beach area to offer the SmoothShapes(R) system ...
... 28 With 27 years of experience in ... Kimberlin-Murphy reveals the behind-the-scenes knowledge she,s cultivated in ... Medical Collector, The Patient,s Guide to Avoiding Bankruptcy" ... the American medical patient and medical community with ...
... are breaking new ground in research"), you will find ... on the opportunities and risks of the whole-body tomographs ... Delbrck Center) in Berlin. , Snap-shots of a diseased ... 7-tesla magnetic resonance tomograph promises scientists novel possibilities. The ...
... PEAK Surgical, Inc., a medical,device company that ... on a,proprietary technology, announced today that it has ... System for use in general surgery. The PEAK,Surgery ... PlasmaBlade(TM),family of disposable, low-temperature surgical cutting and coagulation,devices. ...
... + Fields Dermatologists, the,clinical skincare brand developed by Stanford ... pleased to,announce the recent addition of Robert "Bob" M. Henry ... Fields is the most exciting opportunity in direct selling today.,Following ... future to,be bright," says Henry. , ...
... Uninformed about Cavity-Causing Bacteria and Teeth-Friendly SnacksCHICAGO, Jan. ... the American Academy of Pediatric Dentistry (AAPD), the ... and caregivers are unaware that routine practices, such ... increase children,s risk of developing cavities. To view ...
Cached Medicine News:Health News:Anushka * Cellulite Clinic * Cosmedical Centre Introduces Next Generation Cellulite Treatment 2Health News:Anushka * Cellulite Clinic * Cosmedical Centre Introduces Next Generation Cellulite Treatment 3Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 2Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 3Health News:For sharper pictures of the body's interior 2Health News:PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery 2Health News:PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery 3Health News:Direct Selling Luminary, Robert M. Henry, Partners With Rodan + Fields(R) Dermatologists as Strategic Business Advisor 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 3Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: